After six years of debate, the European Commission's attempts to harmonize biotechnology legislation still face opposition over the patenting of genes. Recent legal experience suggests that its efforts are unnecessary.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moss, G., Cohen, S. Time to abandon Brussels' bid on patents. Nature 372, 384 (1994). https://doi.org/10.1038/372384a0
Issue date:
DOI: https://doi.org/10.1038/372384a0
